Who founded CorriXR Therapeutics?

CorriXR Therapeutics was founded by Eric B. Kmiec in 2022.

Who are CorriXR Therapeutics's investors?

CorriXR Therapeutics's investors include Cortado Ventures.

How much funding has CorriXR Therapeutics raised?

CorriXR Therapeutics has disclosed $6.5M raised across 1 of its 2 known rounds.

Where is CorriXR Therapeutics headquartered?

CorriXR Therapeutics is headquartered in Wilmington, US.

CorriXR Therapeutics

Wilmington, US · Founded 2022 · Delaware corporation · 7 employees on LinkedIn · 1 known investors

Find your way into CorriXR Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the CorriXR Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Corrixr Therapeutics is developing targeted genetic medicine for treatment-resistant cancers, with a focus on advancing its CXR101 therapeutic candidate through clinical development and translational research.

Biotech Medical Devices

Founders & leadership

CorriXR Therapeutics was founded in 2022 by Eric B. Kmiec.

Eric B. KmiecFounder & Chief Scientific Officer

Jeffrey CarperNamed on SEC filing

Jon BrilliantNamed on SEC filing

Deborah MooradNamed on SEC filing

Janice NevinNamed on SEC filing

Stella VnookNamed on SEC filing

Investors · 1

Cortado Ventureslisted by Cortado VenturesOklahoma City

How we know: Cortado Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$6.5M disclosed across 1 of 2 rounds · 2022–2025

▶$6.5MraisedJan 2024 · 4 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jeffrey CarperDirector
Jon BrilliantExecutive Officer
Deborah MooradExecutive Officer, Director
Janice NevinDirector
Stella VnookDirector
Eric KmiecExecutive Officer, Director

Offering amount: $8M
Amount sold: $6.5M
First sale: Jun 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as CorriXR Therapeutics.

In the news

CorriXR Therapeutics Receives $1M Investment from State of Delawarefinsmes.com · Aug 2025

Frequently asked questions

What does CorriXR Therapeutics do?: Corrixr Therapeutics is developing targeted genetic medicine for treatment-resistant cancers, with a focus on advancing its CXR101 therapeutic candidate through clinical development and translational research.
Who founded CorriXR Therapeutics?: CorriXR Therapeutics was founded by Eric B. Kmiec in 2022.
Who are CorriXR Therapeutics's investors?: CorriXR Therapeutics's investors include Cortado Ventures.
How much funding has CorriXR Therapeutics raised?: CorriXR Therapeutics has disclosed $6.5M raised across 1 of its 2 known rounds.
Where is CorriXR Therapeutics headquartered?: CorriXR Therapeutics is headquartered in Wilmington, US.